shortage of glp 1 GLP-1 Agonists Weight Loss Drugs Market Report, 2025-2030 Hims: Is Tomorrow the End

DOI: 10.1016/j.jad.2017.11.063

Are Sulfur Burps a Sign the Medication Is Working

Bode-Boger SM, Boger RH, Galland A, Tsikas D, Frolich J: L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship

Lillys phase 3 ATTAIN-1 results, later published in The New England Journal of Medicine via PubMed, reported average weight loss of 12.4% at the highest dose over 72 weeks in adults with obesity or overweight without type 2 diabetes

Personal health history plays an important role in determining if someone should be prescribed a GLP-1, which is why its important that anyone considering weight loss drugs starts with a conversation with their primary care provider (PCP)